OTCMKTS:ABCZY Abcam (ABCZY) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range$19.40▼$19.4052-Week Range N/AVolume5,400 shsAverage Volume4,712 shsMarket Capitalization$3.98 billionP/E RatioN/ADividend Yield0.36%Price TargetN/A Stock AnalysisStock Analysis Get Abcam alerts: Email Address Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report About Abcam Stock (OTCMKTS:ABCZY)Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Germany, the United Kingdom, and internationally. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. The company also offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc has partnership with Cancer Research UK for the development and commercialization of novel custom antibodies to support the acceleration of cancer research. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.Read More Ad DarwinTop Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.Get Your Free Report ABCZY Stock News HeadlinesMarch 18, 2024 | msn.comLong-standing Danaher executive Markus Lusser becomes new president of AbcamMarch 18, 2024 | finance.yahoo.comAbcam appoints Markus Lusser as new PresidentJuly 27, 2024 | DTI (Ad)How to build the ultimate dividend portfolioThere’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.November 7, 2023 | msn.comDanaher deal for Abcam approved by 89 per cent of shareholdersNovember 6, 2023 | uk.news.yahoo.comAbcam shareholders approve $5.7 billion Danaher dealNovember 1, 2023 | thetimes.co.ukAbcam founder ends fight to block takeoverOctober 23, 2023 | finance.yahoo.comLeading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote "FOR" Danaher Corporation’s Proposed Acquisition of AbcamOctober 21, 2023 | msn.comEfforts to stop takeover of biotech firm Abcam dealt a blowJuly 27, 2024 | DTI (Ad)How to build the ultimate dividend portfolioThere’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.October 19, 2023 | msn.comTop Abcam Investor HBK Voices Support for $5.7 Billion SaleOctober 17, 2023 | stockhouse.comLeading Proxy Advisor, ISS, Recommends Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of AbcamOctober 16, 2023 | proactiveinvestors.comExlusive: Why Abcam founder believes Danaher's acquisition offer falls shortOctober 16, 2023 | msn.comHBK Capital Becomes Biggest Abcam Investor, Set to Support SaleOctober 14, 2023 | msn.comAbcam founder's concern over exodus of British life science companiesOctober 14, 2023 | msn.comAbcam founder speaks out against growing exodus of British life science companiesOctober 12, 2023 | finance.yahoo.comIndependent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to DanaherOctober 5, 2023 | msn.comAbcam received multiple bids in sales process, contacted over 30 partiesOctober 5, 2023 | ft.comLife sciences group Abcam rejects founder’s accusations over $5.7bn deal with DanaherSee More Headlines Receive ABCZY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abcam and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Industrial Inorganic Chemicals Sub-IndustryN/A Current SymbolOTCMKTS:ABCZY Previous SymbolNASDAQ:ABCZY CUSIPN/A CIKN/A Webwww.abcam.com Phone44 1223 696 000FaxN/AEmployees1,492Year Founded1998Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$336.37 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares205,080,000Free FloatN/AMarket Cap$3.98 billion OptionableNot Optionable Beta1.29 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Alan Thomas Hirzel BS (Age 52)MS, MBA, CEO & Exec. Director Mr. Michael Shaun Baldock (Age 54)CFO & Director Dr. Jonathan Simon Milner (Age 55)Co-Founder & Non-Exec. Deputy Chairman Mr. Mark DermodyInterim CIOJames StaveleyVP of Investor RelationsKey CompetitorsJSROTCMKTS:JSCPYMinerals TechnologiesNYSE:MTXTronoxNYSE:TROXKronos WorldwideNYSE:KROLSB IndustriesNYSE:LXUView All Competitors ABCZY Stock Analysis - Frequently Asked Questions Does Abcam have any subsidiaries? Abcam subsidiaries include Abcam Trading (Shanghai) Co. Ltd., Abcam US Group Holdings Inc., Abcam (US) Ltd., and Epitomics Inc. How do I buy shares of Abcam? Shares of ABCZY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ABCZY) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abcam plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abcam With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.